Novartis Whistleblower Wants State FCA Claims Revived

Law360, New York (July 8, 2013, 1:35 PM EDT) -- A former Novartis Pharmaceuticals Corp. employee on Wednesday challenged a Pennsylvania federal judge's decision to ax certain state False Claims Act claims from his whistleblower suit accusing the pharmaceutical giant of ripping off Medicaid by promoting off-label uses of eczema treatment Elidel.

Donald R. Galmines, a former Novartis senior sales consultant, argued in a reconsideration motion that the claims should be reinstated because the federal FCA allows federal courts to have supplemental jurisdiction over state law claims that stem from the same alleged conduct that his...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.